BRPI0314133A8 - Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona - Google Patents

Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona

Info

Publication number
BRPI0314133A8
BRPI0314133A8 BRPI0314133A BR0314133A BRPI0314133A8 BR PI0314133 A8 BRPI0314133 A8 BR PI0314133A8 BR PI0314133 A BRPI0314133 A BR PI0314133A BR 0314133 A BR0314133 A BR 0314133A BR PI0314133 A8 BRPI0314133 A8 BR PI0314133A8
Authority
BR
Brazil
Prior art keywords
epothylone
isolation
methods
cultivation
purifiing
Prior art date
Application number
BRPI0314133A
Other languages
English (en)
Other versions
BR0314133A (pt
Inventor
Benigni Daniel
Stankavage Robert
Chiang Shu-Jen
Hou Hsing
Eagan Bruce
Gu Dennis
Hou David
Mintzmyer Les
P Thully Thomas
L Davis Brian
Hargro Ivan
Mascari Mark
Galvin Gabriel
W Mcconlogue Cary
T Comezoglu Fahri
Stein Gregory
Original Assignee
Bristol Myers Squibb Co
R Pharm Us Operating Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, R Pharm Us Operating Llc filed Critical Bristol Myers Squibb Co
Publication of BR0314133A publication Critical patent/BR0314133A/pt
Publication of BRPI0314133A8 publication Critical patent/BRPI0314133A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCESSO PARA ISOLAMENTO DE EPOTILONA B, MÉTODOS PARA CULTIVO DE MICROORGANISMO QUE PRODUZA EPOTILONA A OU B E PARA PURIFICAÇÃO DE EPOTILONA. A presente invenção refere-se a métodos aperfeiçoados para a produção, isolamento e purificação de epotilona B. Esses métodos incluem, por exemplo, um processo de fermentação para a produção de epotilona B, isolamento através da absorção sobre uma resina e a subseqüente purificação.
BRPI0314133A 2002-09-23 2003-09-22 Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona BRPI0314133A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41299402P 2002-09-23 2002-09-23
PCT/US2003/029628 WO2004026254A2 (en) 2002-09-23 2003-09-22 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b

Publications (2)

Publication Number Publication Date
BR0314133A BR0314133A (pt) 2005-07-12
BRPI0314133A8 true BRPI0314133A8 (pt) 2017-09-19

Family

ID=32030950

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314133A BRPI0314133A8 (pt) 2002-09-23 2003-09-22 Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona

Country Status (22)

Country Link
US (4) US7172884B2 (pt)
EP (3) EP2280014B1 (pt)
JP (2) JP4523843B2 (pt)
KR (2) KR20050053681A (pt)
CN (2) CN1705662B (pt)
AU (1) AU2003275068B2 (pt)
BR (1) BRPI0314133A8 (pt)
CA (3) CA2695671A1 (pt)
CO (1) CO5540384A2 (pt)
ES (2) ES2405753T3 (pt)
GE (1) GEP20074017B (pt)
HR (1) HRP20050278A2 (pt)
IL (2) IL222455A0 (pt)
IS (1) IS7768A (pt)
MX (1) MXPA05003006A (pt)
NO (1) NO334167B1 (pt)
PL (1) PL375902A1 (pt)
RS (1) RS20050235A (pt)
RU (1) RU2368661C2 (pt)
TW (1) TWI291464B (pt)
WO (1) WO2004026254A2 (pt)
ZA (1) ZA200501680B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4274583B2 (ja) 1996-11-18 2009-06-10 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ） エポチロンｃ，ｄ，ｅ及びｆ、製造と薬剤
US6242469B1 (en) * 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6780620B1 (en) 1998-12-23 2004-08-24 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
US6518421B1 (en) 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
WO2002066038A1 (en) 2001-02-20 2002-08-29 Bristol-Myers Squibb Company Treatment of refractory tumors using epothilone derivatives
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2004018478A2 (en) 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
KR20050053681A (ko) * 2002-09-23 2005-06-08 브리스톨-마이어스 스큅 컴퍼니 에포틸론 ｂ의 제조, 분리 및 정제 방법, 및 에포틸론 ｂ의ｘ-선 결정 구조
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20090004277A1 (en) * 2004-05-18 2009-01-01 Franchini Miriam K Nanoparticle dispersion containing lactam compound
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
CN101415420B (zh) * 2006-04-05 2012-09-05 诺瓦提斯公司 用于治疗癌症的治疗剂的组合
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
MY148355A (en) * 2006-08-16 2013-03-29 Novartis Ag Crystal form of epothilone b and use in pharmaceutical compositions
WO2009100571A1 (zh) * 2008-02-01 2009-08-20 Zhejiang Hisun Pharmaceutical Co., Ltd. 一种分离和提纯埃博霉素的方法
NZ588555A (en) 2008-04-24 2012-06-29 Bristol Myers Squibb Co Use of epothilone d in treating tau-associated diseases including alzheimer's disease
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 ａ와 ｂ의 추출 및 정제 방법
CN103183681B (zh) * 2013-03-06 2016-01-13 浙江海正药业股份有限公司 伊沙匹隆的新晶型及其制备方法
EP3036240A1 (en) * 2013-08-19 2016-06-29 Sandoz AG Method for the purifiction of epothilones via crystallization
WO2015024883A1 (en) * 2013-08-19 2015-02-26 Sandoz Ag Method for the purification of epothilones via crystallization
CN104046579B (zh) * 2014-05-16 2016-09-21 虞龙 一株埃博霉素高产菌及其在发酵产埃博霉素中的应用
CN106905338B (zh) * 2017-03-07 2020-06-23 鲁南制药集团股份有限公司 一种埃博霉素b的提纯方法
CN106834377B (zh) * 2017-03-07 2020-05-05 鲁南制药集团股份有限公司 一种生产埃博霉素b的方法
CN107827943B (zh) * 2017-11-28 2022-06-10 绍兴厚普生物科技有限责任公司 一种从发酵液中提取胞嘧啶核苷的方法
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法
KR102440644B1 (ko) * 2020-05-28 2022-09-05 공주대학교 산학협력단 파클리탁셀 정제 시 가스 버블을 이용한 분별침전방법
CN112457320A (zh) * 2020-11-30 2021-03-09 湖北宏中药业股份有限公司 一种提高伊沙匹隆合成反应速率的方法
CN112409369B (zh) * 2020-11-30 2023-03-28 湖北宏中药业股份有限公司 一种埃博霉素b的高效提取纯化方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE879605C (de) 1951-08-05 1953-06-15 Leitz Ernst Gmbh Optisches Instrument mit gekuppeltem Objektiv- und Kondensor-Wechsler
DE3669515D1 (de) * 1985-09-13 1990-04-19 Biotechnolog Forschung Gmbh Makrozyklische antibiotika.
DE4138042C2 (de) 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
ATE218556T1 (de) * 1995-11-17 2002-06-15 Biotechnolog Forschung Gmbh Epothilon-derivate und deren herstellung
DE19639456A1 (de) 1996-09-25 1998-03-26 Biotechnolog Forschung Gmbh Epothilon-Derivate, Herstellung und Mittel
DE19542986A1 (de) 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung
DE19645361A1 (de) 1996-08-30 1998-04-30 Ciba Geigy Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
DE19645362A1 (de) 1996-10-28 1998-04-30 Ciba Geigy Ag Verfahren zur Herstellung von Epothilon A und B und Derivaten
DE19636343C1 (de) 1996-08-30 1997-10-23 Schering Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
AU716610B2 (en) 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
JP4274583B2 (ja) * 1996-11-18 2009-06-10 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ） エポチロンｃ，ｄ，ｅ及びｆ、製造と薬剤
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6242469B1 (en) * 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
DE19701758A1 (de) 1997-01-20 1998-07-23 Wessjohann Ludgar A Dr Epothilone-Synthesebausteine
EP1201666A3 (de) 1997-02-25 2003-03-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Seitenkettenmodifizierte Epothilone
DE19713970B4 (de) 1997-04-04 2006-08-31 R&D-Biopharmaceuticals Gmbh Epothilone-Synthesebausteine II - Prenylderivate
EP0975622B1 (de) 1997-04-18 2002-10-09 Studiengesellschaft Kohle mbH Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium
DE19720312A1 (de) 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
DE19821954A1 (de) 1997-05-15 1998-11-19 Biotechnolog Forschung Gmbh Verfahren zur Herstellung eines Epothilon-Derivats
DE19726627A1 (de) 1997-06-17 1998-12-24 Schering Ag Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
ES2184307T3 (es) 1997-07-16 2003-04-01 Schering Ag Derivados de tiazol, procedimiento para su preparacion y su utilizacion.
CA2299608A1 (en) 1997-08-09 1999-02-18 Schering Aktiengesellschaft New epothilone derivatives, method for producing same and their pharmaceutical use
US6320045B1 (en) 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
US6365749B1 (en) 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
MY125921A (en) 1998-02-05 2006-08-30 Novartis Ag Compositions containing organic compounds
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
JP2002504540A (ja) 1998-02-25 2002-02-12 スローン−ケッタリング インスティトゥート フォア キャンサー リサーチ エポチロンの合成、その中間体およびそのアナログ
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
FR2776071B1 (fr) * 1998-03-13 2000-05-26 Eastman Kodak Co Dispositif de mesure automatique de la concentration d'un agent developpateur
US6380395B1 (en) 1998-04-21 2002-04-30 Bristol-Myers Squibb Company 12, 13-cyclopropane epothilone derivatives
WO2000000485A1 (de) 1998-06-30 2000-01-06 Schering Aktiengesellschaft Epothilon-derivate, verfahren zu deren herstellung, zwischenprodukte und ihre pharmazeutische verwendung
KR100851418B1 (ko) * 1998-11-20 2008-08-08 코산 바이오사이언시즈, 인코포레이티드 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
AU2795000A (en) 1998-12-22 2000-07-12 Novartis Ag Epothilone derivatives and their use as antitumor agents
CA2356360A1 (en) 1998-12-23 2000-07-06 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
NZ513268A (en) 1999-02-18 2004-05-28 Schering Ag 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
WO2000050423A1 (en) 1999-02-22 2000-08-31 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf) C-21 modified epothilones
US6211412B1 (en) * 1999-03-29 2001-04-03 The University Of Kansas Synthesis of epothilones
PE20010116A1 (es) 1999-04-30 2001-02-15 Schering Ag Derivados de 6-alquenil-, 6-alquinil- y 6-epoxi-epotilona, procedimientos para su preparacion
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
CN1142163C (zh) * 2002-02-07 2004-03-17 山东大学 一种从粘细菌发酵液中分离提纯埃博霉素的方法
TW200303202A (en) * 2002-02-15 2003-09-01 Bristol Myers Squibb Co Method of preparation of 21-amino epothilone derivatives
KR20050053681A (ko) * 2002-09-23 2005-06-08 브리스톨-마이어스 스큅 컴퍼니 에포틸론 ｂ의 제조, 분리 및 정제 방법, 및 에포틸론 ｂ의ｘ-선 결정 구조

Also Published As

Publication number Publication date
EP2280014B1 (en) 2013-10-23
TWI291464B (en) 2007-12-21
CA2695671A1 (en) 2004-04-01
HK1113387A1 (en) 2008-10-03
CN101050445B (zh) 2011-08-10
IS7768A (is) 2005-03-22
ZA200501680B (en) 2006-05-31
CN1705662A (zh) 2005-12-07
RU2005112443A (ru) 2005-10-27
CA2695720C (en) 2013-04-02
KR20120080649A (ko) 2012-07-17
EP2287168A3 (en) 2011-03-16
US7172884B2 (en) 2007-02-06
RU2368661C2 (ru) 2009-09-27
CA2499600C (en) 2012-08-21
PL375902A1 (en) 2005-12-12
ES2439995T3 (es) 2014-01-27
ES2405753T3 (es) 2013-06-03
NO20050929L (no) 2005-04-08
BR0314133A (pt) 2005-07-12
EP2287168A2 (en) 2011-02-23
USRE42191E1 (en) 2011-03-01
CO5540384A2 (es) 2005-07-29
GEP20074017B (en) 2007-01-10
WO2004026254A3 (en) 2004-05-27
KR101406635B1 (ko) 2014-06-11
KR20050053681A (ko) 2005-06-08
CN101050445A (zh) 2007-10-10
EP2280014A2 (en) 2011-02-02
TW200409773A (en) 2004-06-16
EP2280014A3 (en) 2011-08-03
JP4523843B2 (ja) 2010-08-11
AU2003275068A1 (en) 2004-04-08
HRP20050278A2 (en) 2005-10-31
CN1705662B (zh) 2011-07-06
US7767432B2 (en) 2010-08-03
AU2003275068B2 (en) 2009-09-17
NO334167B1 (no) 2013-12-23
IL166868A (en) 2012-12-31
RS20050235A (sr) 2007-06-04
EP1542998A2 (en) 2005-06-22
US20060135474A1 (en) 2006-06-22
US20040132146A1 (en) 2004-07-08
JP2010011873A (ja) 2010-01-21
IL222455A0 (en) 2012-12-02
WO2004026254A2 (en) 2004-04-01
CA2695720A1 (en) 2004-04-01
US20070122891A1 (en) 2007-05-31
JP5193983B2 (ja) 2013-05-08
CA2499600A1 (en) 2004-04-01
EP2287168B1 (en) 2013-02-13
JP2006500031A (ja) 2006-01-05
US7241899B2 (en) 2007-07-10
MXPA05003006A (es) 2005-06-22
EP1542998A4 (en) 2007-01-31

Similar Documents

Publication Publication Date Title
BR0314133A (pt) Métodos para a preparação, isolamento e purificação de epotilona b e raios x de estruturas de cristal de epotilona b
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
BR0312379A (pt) Produtos de poliadição contendo grupos uretodiona
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
DE60120209D1 (de) Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
BRPI0512987A (pt) processo para preparar compostos, composto, uso do mesmo, e, material de revestimento termicamente curável, curável por radiação ou de cura dupla
BR0208265A (pt) Redução estereosseletiva de acetofenona substituìda
BR0109188A (pt) Diarilaminas 5-amida substituìdas como inibidores de mex
DE602007005496D1 (de) Ezymatisches verfahren zur herstellung von 2-o-glyceryl-alpha-d-glucopyranosid
BR0116332A (pt) Processo para o aumento da estabilidade
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
BRPI0411738A (pt) compostos orgánicos
DE60219960D1 (de) Verfahren zur herstellung von isopropanol
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
BRPI0413139A (pt) processo para a preparação de l-treonina
BR0115991A (pt) Processo para o isolamento e a purificação de epotilonas
BR0301983A (pt) Processo para a esterilização e/ou redução de germes de materiais de moldagem
WO2004017949A3 (de) Prophylaxe und therapie von infektionserkrankungen mit amitryptilin oder imipramin oder desipramin oder fgf oder einem anticeramid antikörper oder cyclodextrin oder nystatin oder filipin
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
BR0309753A (pt) Processo para a preparação de derivados de 6-alquilideno penem
BRPI0412119A (pt) processo para a produção de ésteres a partir de epóxidos
ECSP077220A (es) Tratamiento de infecciones bacterianas
BRPI0411741A (pt) triazolopirimidinas
ATE257818T1 (de) Verfahren zur herstellung von wasserfreier gabapentin von pharmazeutischer qualität
BR0113170A (pt) Processo para a preparação de dinapsolina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: R-PHARM US OPERATING, LLC (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 417/06

Ipc: C12P 17/18 (1980.01), C12N 1/20 (1980.01), C07D 41

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.